Johnson & Johnson

$129.20
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.18 (+0.92%) Today
$0.00 (0.00%) As of 5:50 PM EDT after-hours

Why Robinhood?

You can buy or sell JNJ and other stocks, options, ETFs, and crypto commission-free!

About JNJ

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. Read More The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Employees
135,100
Headquarters
New Brunswick, New Jersey
Founded
1887
Market Cap
337.87B
Price-Earnings Ratio
20.00
Dividend Yield
2.78
Average Volume
10.49M
High Today
$130.54
Low Today
$128.09
Open Price
$128.75
Volume
7.63M
52 Week High
$148.99
52 Week Low
$121.00

Collections

JNJ News

Reuters9h

Johnson & Johnson CEO testified Baby Powder was safe 13 days before FDA bombshell

LOS ANGELES/NEW YORK (Reuters) - Facing off against a plaintiff’s lawyer for the first time about Johnson & Johnson’s Baby Powder, the company’s Chief Executive
39
BenzingaOct 21

How Much Litigation Risk Is Priced Into Johnson & Johnson?

Johnson & Johnson (NYSE: JNJ) just can't seem to shake its talcum powder problems. On Friday, Johnson & Johnson recalled 33,000 bottles of baby powder after a
656
Washington PostOct 21

Ohio counties, drug firms reach $260 million settlement in opioid epidemic case, averting trial

Details of the agreement were set to be announced later Monday morning. Late last night, the companies were still negotiating. AD AD Going to trial could hav
65

JNJ Earnings

$1.95
$2.16
$2.37
$2.58
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
$2.00 per share
Actual
$2.12 per share

Popular Stocks

More JNJ News

BenzingaOct 19

Benzinga's Bulls And Bears Of The Week: Beyond Meat, Netflix, Johnson & Johnson And More

Benzinga has examined the prospects for many investor favorite stocks over the past week. Bullish calls included a second-tier telecom and a fast-casual restau
10,218
Washington PostOct 18

Johnson & Johnson recalls one lot of baby powder after trace amounts of asbestos found

The voluntary recall is limited to one lot of Johnson’s Baby Powder produced and shipped in the United States in 2018, the company said. Johnson & Johnson said
280
BloombergOct 18

J&J Recalls Lot of Baby Powder After Asbestos Trace Found

(Bloomberg) -- Johnson & Johnson is recalling one lot of its Johnson’s Baby Powder after tiny amounts of asbestos contamination were found in samples from a sin
60
ReutersOct 18

J&J recalls 33,000 bottles of baby powder as FDA finds asbestos in sample

(Reuters) - Johnson & Johnson (JNJ.N) said on Friday it is recalling around 33,000 bottles of baby powder in the United States after U.S. health regulators foun
70
MarketWatchOct 18

Dow ends lower pressured by Boeing, Johnson & Johnson, despite good earnings

Dow ends lower pressured by Boeing, Johnson & Johnson, despite good earnings More Dow sheds more than 250 points after data showed China’s economic growth slow
4
MarketWatchOct 18

The most generous country in the world and how much parents should worry about a Johnson & Johnson baby powder recall and arsenic in baby food

Happy Friday - and a happy weekend - MarketWatchers! Don’t miss these top stories: NBA analyst Stan Van Gundy on how the league has changed: ‘No one called the
0
Washington PostOct 18

Coca-Cola, Schlumberger advance while J&J, Gildan retreat

ETrade Financial Corp., up $1.81 to $40.85 The online brokerage beat Wall Street’s third-quarter profit and revenue forecasts. Schlumberger NV, up 42 cents to
37
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.